Skip to main content
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America logoLink to Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
letter
. 2017 Oct 13;66(1):159–160. doi: 10.1093/cid/cix750

The Critical Importance of Sampling Fraction to Inferences of Mycobacterium tuberculosis Transmission

Robyn S Lee 1,, Benjamin P Howden 1
PMCID: PMC5850540  PMID: 29040477

To the Editor—In the study by Manson et al [1], whole-genome sequencing was performed on 223 Mycobacterium tuberculosis isolates from the Tiruvallur and Madurai districts of India. They subsequently examined local strain diversity and mutations associated with phenotypic drug resistance in these regions. In this important study, the authors show that lists of published resistance mutations (including [2–4]) have lower positive predictive values for phenotypic resistance in this context; lineages 1 and 3 predominate in India [1], but these published mutations were largely identified using strains from different M. tuberculosis lineages. This highlights a key obstacle to the implementation of genomics for resistance prediction in India and potentially other endemic regions with diverse lineages of M. tuberculosis. By extension, this study emphasizes the critical need to collect strains and categorize the mutations circulating in these regions to better inform such predictions.

Although we reiterate the importance of this work, we have some considerations that warrant further attention. First, we note that the authors apply a threshold of 10 single nucledotide polymorphisms (SNPs) distance for “recent transmission,” stating this threshold was derived in previous publications. Given this, they then conclude that transmission “was occurring among patients from the same and not different regions.” We would argue that this inference cannot be made from the data available in this study. The sampling fraction, which corresponds to the proportion of total cases included in the study, is an essential (yet often overlooked) consideration in genomic epidemiology. Previous studies have shown that, as sampling fraction decreases, clustering is underestimated [5, 6]. With a low sampling fraction, numerous potential transmission events may be missed due to failure to observe source or secondary cases. When making inferences about transmission in genomic epidemiology (or deciding which inferences should be made), this is therefore a critical consideration [7]. In the Manson et al study, the authors included samples from 196 unique patients from 2 districts of India that were collected over a 6-year period. Because India accounts for >2 million cases of tuberculosis per year [8], the Manson et al study clearly includes only a small proportion of the total cases that would have been diagnosed in this time. We therefore argue that transmission between districts cannot and should not be excluded. To do so not only sends a potentially erroneous message to regional public health units but also risks promoting a “silo effect,” wherein public health officials within regions overlook risk factors for transmission beyond their administrative borders, which may ultimately prove detrimental to tuberculosis control in India and elsewhere.

We would also caution about the general application of SNP thresholds derived from external studies. Although such thresholds are useful from a public health perspective, it is important to note that their sensitivity and specificity for transmission often depends on local strain diversity (eg, [9]) and may not be readily transferrable across settings. We agree that ≤10 SNPs distance does suggest a close genetic relationship; however, it is important to keep in mind that direct person-to-person transmission cannot be ruled in absent more detailed epidemiologic and contextual data.

Notes

Financial support. R. S. L. is supported by a Fellowship from the Canadian Institutes of Health Research (Funding Reference Number 152448). B. P. H. holds a Practitioner Fellowship from the National Health and Medical Research Council, Australia (GNT1105905).

Potential conflicts of interest. Both authors: No reported conflicts of interest. Both authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.

References

  • 1. Manson AL, Abeel T, Galagan JE et al. Mycobacterium tuberculosis whole genome sequences from Southern India suggest novel resistance mechanisms and the need for region-specific diagnostics. Clin Infect Dis 2017; 64:1494–501. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Coll F, McNerney R, Preston MD et al. Rapid determination of anti-tuberculosis drug resistance from whole-genome sequences. Genome Med 2015; 7:51. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Walker TM, Kohl TA, Omar SV et al. ; Modernizing Medical Microbiology (MMM) Informatics Group Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort study. Lancet Infect Dis 2015; 15:1193–202. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Cohen KA, Abeel T, Manson McGuire A et al. Evolution of extensively drug-resistant tuberculosis over four decades: whole genome sequencing and dating analysis of Mycobacterium tuberculosis isolates from KwaZulu-Natal. PLoS Med 2015; 12:e1001880. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Murray M. Sampling bias in the molecular epidemiology of tuberculosis. Emerg Infect Dis 2002; 8:363–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Glynn JR, Vynnycky E, Fine PE. Influence of sampling on estimates of clustering and recent transmission of Mycobacterium tuberculosis derived from DNA fingerprinting techniques. Am J Epidemiol 1999; 149:366–71. [DOI] [PubMed] [Google Scholar]
  • 7. Guthrie JL, Gardy JL. A brief primer on genomic epidemiology: lessons learned from Mycobacterium tuberculosis. Ann N Y Acad Sci 2017; 1388:59–77. [DOI] [PubMed] [Google Scholar]
  • 8. World Health Organization. Global Tuberculosis Report 2016. Geneva, Switzerland: World Health Organization; 2016. [Google Scholar]
  • 9. Lee RS, Radomski N, Proulx JF et al. Reemergence and amplification of tuberculosis in the Canadian arctic. J Infect Dis 2015; 211:1905–14. [DOI] [PubMed] [Google Scholar]

Articles from Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America are provided here courtesy of Oxford University Press

RESOURCES